Drug intelligence / Profile preview

melinjo seed ethyl acetate fraction

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Melinjo seed ethyl acetate fraction is an **early-stage natural product extract** prepared from the seeds of *Gnetum gnemon* through ethanol extraction followed by ethyl acetate fractionation. It is best characterized as a **small molecule phytochemical mixture** enriched in polyphenolic constituents, including **resveratrol derivatives** such as **gnetin C** and **gnemonoside A**. Preclinical academic studies have reported **antioxidant activity**, **cytotoxicity against cancer cell lines** including breast cancer MCF-7 and cervical cancer HeLa cells, and **angiotensin-converting enzyme inhibition**, suggesting possible antineoplastic and antihypertensive potential. However, it does **not appear to have an identified commercial sponsor, brand, manufacturing program, or clinical-stage development**, and the observed activity is better understood as arising from a multi-constituent phenolic extract rather than a single defined molecular target.

Other names
melinjo seed ethyl acetate fractionethyl acetate fraction of melinjo seedsGnetum gnemon seed ethyl acetate fractionmelinjo seed extract ethyl acetate fraction
02

Targets

ACE (Angiotensin Converting Enzyme)

Beyond the preview

Go deeper on melinjo seed ethyl acetate fraction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on melinjo seed ethyl acetate fraction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call